Oruka Therapeutics expands license agreement to include IBD indication

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. IBM
3. PRIM
4. MU
5. DPZ
6. NAVN
7. DFTX
8. META
9. IMNN
10. ACN

Go back to Oruka Therapeutics expands license agreement to include IBD indication
(NASDAQ: ORKA) Delayed: 85.38 --0 (-0%)
Previous Close $85.38    52 Week High $ 
Open $85.38    52 Week Low $ 
Day High $85.38    P/E N/A 
Day Low $85.38    EPS $ 
Volume 2,063